- $34.07bn
- $33.26bn
- $5.65bn
Brief: Resmed To Report Third Quarter Fiscal 2025 Earnings On April 23, 2025
Resmed's Australian shares fall after insider Ghoshal sells stock
Brief: Resmed Unveils Unified Brand To Lead The Global Sleep And Health Technology Revolution
U.S. STOCKS ON THE MOVE-Moderna, Hims & Hers Health, Carrier
ResMed slips after Stifel cuts PT
U.S. STOCKS ON THE MOVE-Moderna, Hims & Hers Health, Carrier
Resmed's Australia shares fall; Macquarie hikes PT
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Resmed Inc reports results for the quarter ended December 31 - Earnings Summary
ResMed beats quarterly profit estimates on demand for sleep disorder devices
Brief: Resmed Q2 Adjusted EPS USD 2.43 Vs. IBES Estimate USD 2.31
Morning Bid Americas: Megacaps mixed as Fed pauses; ECB cut and GDP up next
U.S. STOCKS ON THE MOVE-Cruise stocks, US airline stocks
Sleep apnea device makers end year with mix performance despite GLP-1 concerns
Lilly gains as weight-loss drug approved for sleep apnea
Focus: Weight-loss drugs draw Americans back to the doctor
Focus: Weight-loss drugs draw Americans back to the doctor (updated)
Focus: Weight-loss drugs draw Americans back to the doctor
Resmed Inc reports results for the quarter ended in September 30 - Earnings Summary